
Lenacapavir is a long-acting HIV capsid inhibitor that has demonstrated high effectiveness in preventing HIV acquisition when used as PrEP. Click on the link below to read our full blog riattesa.org/can-twice-yearl…

A platform of regional stakeholders aimed at improving the response to children affected by AIDS in East and Southern Africa. RTs & Follows are not endorsements

Lenacapavir is a long-acting HIV capsid inhibitor that has demonstrated high effectiveness in preventing HIV acquisition when used as PrEP. Click on the link below to read our full blog riattesa.org/can-twice-yearl…

WEBINAR ANNOUNCEMENT 📅 Date: Friday, 18 September 2026 ⏰ Time: 10:00 AM – 11:30 AM SAST 🔗 Join the webinar: lnkd.in/dxKp2Z9Y Join us as we challenge misinformation, amplify the voices and experiences of key populations, and strengthen HIV and SRH responses across ESA

🔹 Strengthen cross-border health systems 🔹 Explicitly include migrant AYP 🔹 Strengthen evidence & accountability Migration status should never determine access to essential healthcare. #RIATTESA #HIV #SRHR #MigrantYouth #HealthEquity #SADC #EAC



RIATT-ESA joined governments, African Union institutions, civil society organisations, child protection actors, experts and development partners at the ARISE Africa II Convening, held at the African Union Headquarters from 16–17 July 2026 riattesa.org/riatt-esa-joins…

UNAIDS has released a new special report for the 26th International AIDS Conference 2026. Read full report here riattesa.org/unaids-releases…






Age of Consent Laws Should Protect Adolescents, Not Prevent Them from Accessing Healthcare - RIATT-ESA riattesa.org/towards-a-trans…

Join the conversation by scanning the QR code or clicking on the link events.teams.microsoft.com/e…

Happy International Day of the African Child. RIATT-ESA reaffirms its commitment to advocating for policies, programmes, and investments that place children at the centre of development efforts. #childhealthfinancing #RIATT-ESA

The 1st edition of the HIV, Infectious Diseases, and Global Health Science of Implementation Conference (VISTA) Abstract submission is open - abstract submission deadline is: Friday, 26 June 2026 at 23:59 CET. For information, check the link below. lnkd.in/dz2wicS7